3-((((3R,5R)-3-butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl)methyl)amino)pentanedioic acid,
GSK2330672,
GSK2330672,
1345982-69-5,
GSK-2330672,
Iinerixibat,
Linerixibat,
UNII-386012Z45S,
CHEMBL2387408,
386012Z45S,
3-[[[(3R,5R)-3-butyl-3-ethyl-2,3,4,5-tetrahydro-7-methoxy-1,1-dioxido-5-phenyl-1,4-benzothiazepin-8-yl]methyl]amino]pentanedioic acid,
CZGVOBIGEBDYTP-VSGBNLITSA-N,
Linerixibat [USAN],
SCHEMBL2586025,
BCP17155,
EX-A1180,
BDBM50434858,
MFCD28386358,
WHO 10729,
ZINC96270862,
AKOS030526427,
CS-5447,
DB11729,
SB17413,
GSK 2330672,
AS-35059,
HY-16643,
Pentanedioic acid, 3-((((3R,5R)-3-butyl-3-ethyl-2,3,4,5-tetrahydro-7-methoxy-1,1-dioxido-5-phenyl-1,4-benzothiazepin-8-yl)methyl)amino)-,
FT-0700172,
GSK 2330672;GSK-2330672,
J-690137,
3-({[(3R,5R)-3-butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}amino)pentanedioic acid,
Verdinexor,